Published on Medical Design Technology (http://www.mdtmag.com)

Home > NuVasive wins FDA approval for PCM spine implant

NuVasive wins FDA approval for PCM spine implant

Mass Device

NuVasive says the FDA granted pre-market approval to its PCM cervical disc system, sending shares up on Wall Street today.

NuVasive

NuVasive Inc. [1] (NSDQ:NUVA [2]) said the FDA granted pre-market approval for its PCM cervical disc implant, sending NUVA shares up more than 2% on Wall Street today.

The San Diego-based medical device company said the implant is designed to preserve motion in the cervical spine, in lieu of a standard fusion procedure. The FDA nod came after a 403-patient investigation device exemption trial, according to NuVasive.

NUVA shares were trading at $14.23 as of about 12:30 p.m. today, up 2.3%.

Source URL (retrieved on 05/22/2013 - 4:51am): http://www.mdtmag.com/news/2012/10/nuvasive-wins-fda-approval-pcm-spine-implant

Links:
[1] http://www.massdevice.com/company/nuvasive-inc
[2] http://www.google.com/finance?q=NASDAQ%3ANUVA